ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Reevaluation Of Systemic Early Neuromuscular Blockade

ClinicalTrials.gov ID: NCT02509078

Public ClinicalTrials.gov record NCT02509078. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 24, 2026, 2:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02509078
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Massachusetts General Hospital
Other
Enrollment
1,008 participants

Conditions and interventions

Interventions

  • Cisatracurium Besylate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 3, 2016
Primary completion
Jul 2, 2018
Completion
Apr 3, 2019
Last update posted
Aug 12, 2019

2016 – 2019

United States locations

U.S. sites
44
U.S. states
17
U.S. cities
36
Facility City State ZIP Site status
UCSF Fresno Fresno California 93701
Ronald Reagan UCLA Medical Center Los Angeles California 90095
UC Davis Medical Center Sacramento California 95817
UCSF Medical Center San Francisco California 94143
Stanford University Hospital Stanford California 94305
Medical Center of Aurora Aurora Colorado 80045
University of Colorado Hospital Aurora Colorado 80045
Denver Health Medical Center Denver Colorado 80204
Swedish Medical Center Englewood Colorado 80113
Indiana University Methodist Hospital Indianapolis Indiana 46220
University Medical Center New Orleans Louisiana 70112
Maine Medical Center Portland Maine 04102
Tufts Medical Center Boston Massachusetts 02111
Massachusetts General Hospital Boston Massachusetts 02114
Brigham and Women's Hospital Boston Massachusetts 02115
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Baystate Medical Center Springfield Massachusetts 01199
St. Vincent's Hospital Worcester Massachusetts 01608
University of Michigan Medical Center Ann Arbor Michigan 48109
Henry Ford Medical Center Detroit Michigan 48025
University of Mississippi Medical Center Jackson Mississippi 39216
Mt. Sinai Hospital New York New York 10029
Montefiore Medical Center The Bronx New York 10467
Wesley Long Hospital Greensboro North Carolina 27403
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157
Summa Akron City Hospital Akron Ohio 44304
University of Cincinnati Medical Center Cincinnati Ohio 45219
Cleveland Clinic Foundation Cleveland Ohio 44195
Ohio State University Wexner Medical Center Columbus Ohio 43210
Oregon Health and Science University Portland Oregon 97239
Penn State Hershey Medical Center Hershey Pennsylvania 17033
UPMC Presbyterian/Mercy/Shadyside Pittsburgh Pennsylvania 15261
Vanderbilt University Medical Center Nashville Tennessee 37221
Intermountain Medical Center Murray Utah 84107
McKay-Dee Hospital Ogden Utah 84403
Utah Valley Regional Medical Center Provo Utah 84604
University Hospital Salt Lake City Utah 84132
LDS Hospital Salt Lake City Utah 84143
University or Virginia Health System Charlottesville Virginia 22903
VCU Medical Center Richmond Virginia 23298
Harborview Medical Center Seattle Washington 98104
University of Washington Medical Center Seattle Washington 98104
Swedish Hospital Cherry Hill Seattle Washington 98122
Swedish Hospital First Hill Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02509078, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 12, 2019 · Synced Apr 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02509078 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →